Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06428643
Other study ID # 2024-377
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 1, 2024
Est. completion date September 1, 2029

Study information

Verified date May 2024
Source Tulane University
Contact Patricia Kissinger, PhD
Phone 504-988-7320
Email kissing@tulane.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study includes testing for four STIs (chlamydia, gonorrhea, syphilis, and HIV) at no cost. If positive, individual subjects will also be counseled and offered options for treatment for themselves and their sex partners that may include no cost expedited treatment and the option to be rescreened 3 months after treatment.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 2322
Est. completion date September 1, 2029
Est. primary completion date September 1, 2028
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 15 Years to 26 Years
Eligibility Inclusion Criteria: - Identifies as African American or Black - 15-26 years of age - Lives or spends most of their time in Orleans Parish - Had vaginal sex at least once Exclusion Criteria: - Unwilling or unable to provide informed consent - Unable to speak or understand English - Previously enrolled in the study - Known to be pregnant - Known HIV positive status

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Chlamydia, gonorrhea, syphilis, and HIV screening
Individuals aged 15-26 years old will be tested for chlamydia, gonorrhea, HIV, and syphilis at community based venues. Individuals who test positive for chlamydia and gonorrhea and their sexual partners will be offered expedited treatment at participating pharmacies. Individuals who test positive will be asked to be rescreened for Ct/GC at 3 months post treatment.

Locations

Country Name City State
n/a

Sponsors (3)

Lead Sponsor Collaborator
Tulane University National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of chlamydia in women Primary outcome up to 60 months
Secondary Rate of gonorrhea in women Secondary outcome up to 60 months
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2